Page last updated: 2024-11-05

trazodone and Ataxias, Hereditary

trazodone has been researched along with Ataxias, Hereditary in 1 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Research Excerpts

ExcerptRelevanceReference
"Polysomnography showed sleep apnea."1.27Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone. ( Roos, RP; Rosenberg, RS; Salazar-Grueso, EF, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salazar-Grueso, EF1
Rosenberg, RS1
Roos, RP1

Other Studies

1 other study available for trazodone and Ataxias, Hereditary

ArticleYear
Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone.
    Annals of neurology, 1988, Volume: 23, Issue:4

    Topics: Adult; Humans; Male; Olivopontocerebellar Atrophies; Sleep Apnea Syndromes; Spinocerebellar Degenera

1988